Protective effect of L-arginine on gentamicin-induced nephrotoxicity in rats

Indian Journal of Pharmacology

Volumn 46, Issue 6, 2014, Pages 608-612

  Bashan, Lbrahim ^a   Bashan, Perihan ^b   Seçilmis, Mehmet Ata ^b   Singirik, Ergin ^b  

^a MERSIN UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

D arginine; gentamicin; HPLC; L arginine; nephrotoxicity

Indexed keywords

ARGININE; CREATININE; DEXTRO ARGININE; GAMMA GLUTAMYLTRANSFERASE; GENTAMICIN; NITRIC OXIDE; POTASSIUM; SODIUM; ANTIINFECTIVE AGENT; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG MECHANISM; DRUG URINE LEVEL; FLUID INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; MALE; NEPHROTOXICITY; NONHUMAN; POTASSIUM BLOOD LEVEL; RAT; RENAL PROTECTION; SODIUM BLOOD LEVEL; SODIUM EXCRETION; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINARY EXCRETION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMICALLY INDUCED; KIDNEY DISEASES; METABOLISM; PATHOLOGY; URINE; WISTAR RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; ARGININE; BLOOD UREA NITROGEN; CREATININE; GENTAMICINS; KIDNEY DISEASES; MALE; POTASSIUM; PROTECTIVE AGENTS; RATS; RATS, WISTAR; SODIUM;

EID: 84916242019     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.144915     Document Type: Article

References (25)

1. Balakumar P, Rohilla A, Thangathirupathi A. Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it? Pharmacol Res 2010; 62: 179-86
2. Martinez-Salgado C, Lopez-Hernandez FJ, Lopez-Novoa JM. Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacol 2007; 223: 86-98
3. Stojiljkovic N, Mihailovic D, Veljkovic S, Stoiljkovic M, Jovanovic I. Glomerular basement membrane alterations induced by gentamicin administration in rats. Exp Toxicol Pathol 2008; 60: 69-75
4. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 1997; 29: 465-77
5. Walker PD, Barri Y, Shah SV. Oxidant mechanisms in gentamicin nephrotoxicity. Ren Fail 1999; 21: 433-42
6. Ghaznavi R, Faghihi M, Kadkhodaee M, Shams S, Khastar H. Effects of nitric oxide on gentamicin toxicity in isolated perfused rat kidneys. J Nephrol 2005; 18: 548-52
7. Ozbek E, Turkoz Y, Sahna E, Ozugurlu F, Mizrak B, Ozbek M. Melatonin administration prevents the nephrotoxicity induced by gentamicin. BJU Int 2000; 85: 742-6
8. Rivas-Cabanero L, Montero A, Lopez-Novoa JM. Increased glomerular nitric oxide synthesis in gentamicin-induced renal failure. Eur J Pharmacol 1994; 270: 119-21
9. Saavedra-Molina A, Pina E. Stimulation of L-ornithine uptake and L-citrulline and urea biosynthesis by D-Arginine. Biochem Int 1991; 24: 349-57
10. Noda Y, Yamada K, Furukawa H, Nabeshima T. Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice. Eur J Pharmacol 1995; 286: 291-7
11. Calver A, Collier J, Vallance P. Dilator actions of arginine in human peripheral vasculature. Clin Sci (Lond) 1991; 81: 695-700
12. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 1999; 33: 937-42
13. Chambers DC, Ayres JG. Effect of nebulised L-And D-Arginine on exhaled nitric oxide in steroid naive asthma. Thora 2001; 56: 602-6
14. McVeigh GE, Allen PB, Morgan DR, Hanratty CG, Silke B. Nitric oxide modulation of blood vessel tone identifed by arterial waveform analysis. Clin Sci (Lond) 2001; 100: 387-93
15. Nagai J, Komeda T, Yumoto R, Takano M. Effect of protamine on the accumulation of gentamicin in opossum kidney epithelial cells. J Pharm Pharmacol 2013; 65: 441-6
16. Nagai J, Komeda T, Katagiri Y, Yumoto R, Takano M. Characterization of protamine uptake by opossum kidney epithelial cells. Biol Pharm Bull 2013; 36: 1942-9
17. Can C, Sen S, Boztok N, Tuglular I. Protective effect of oral L-Arginine administration on gentamicin-induced renal failure in rats. Eur J Pharmacol 2000; 390: 327-34
18. Kafkas E, Ozgen M, Ozogul Y, Türemis N. Phytochemical and fatty acid profi le of selected red raspberry cultivars: A comparative study. J Food Qual 2008; 1: 67-78
19. Mingeot-Leclercq MP, Tulkens PM. Aminoglycosides: Nephrotoxicity. Antimicrob Agents Chemother 1999; 43: 1003-12
20. Zaske DE. Aminoglycosides. In: Ewans WE, Schentag JJ, Jusko WJ, editors. Applied Pharmocokinetics. Principles of Therapeutic Drug Monitoring. 3rd ed. Vancouver: WA; 1992. p. 141-7
21. Karatas Y, Secilmis MA, Karayaylali ̄, Doran F, Buyukafsar K, Singirik E, et al. Effect of tempol (4-hydroxy tempo) on gentamicin-induced nephrotoxicity in rats. Fundam Clin Pharmacol 2004; 18: 79-83
22. Secilmis MA, Karatas Y, Yorulmaz O, Buyukafsar K, Singirik E, Doran F, et al. Protective effect of L-Arginine intake on the impaired renal vascular response s in the gentamicin-Treated rats. Nephron Physiol 2005; 100: p13-20
23. Balsam L, Nikbakht N. L-Arginine inhibits vasopressin-stimulated mesangial cell Ca2+. Am J Physiol 1998; 275: C352-7
24. Matsamura Y, Nishiura M, Deuchi S, Hashimato N, Ogawa T, Seo R. Protective effect of FK409, a spontenous nitric oxide releaser, on ischemic acute renal failure in rats. J Pharmacol Exp Ther 1998; 287: 1084-91
25. Noiri E, Peresieni T, Miller F, Goligorsky MS. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 1996; 97: 2377-83